Shweta Urva

Title: Shweta Urva: Innovator in Glycemic Control and Weight Management

Introduction

Shweta Urva is a prominent inventor based in Indianapolis, IN (US). She has made significant contributions to the field of medical therapies, particularly in glycemic control and weight management. With a total of 3 patents to her name, her work is paving the way for innovative treatments in diabetes and related conditions.

Latest Patents

Shweta's latest patents include groundbreaking methods and compositions involving an incretin analog. One of her notable inventions is a method for using a GIP/GLP1 co-agonist for therapy. This invention provides a method for increasing glycemic control in patients by administering tirzepatide or a pharmaceutically acceptable salt thereof. Additionally, it outlines a method for improving weight management in patients, as well as treating conditions such as atherosclerosis, chronic kidney disease, NAFLD, and NASH. Furthermore, her patent includes a dosing regimen aimed at enhancing glycemic control, improving weight management, and treating dyslipidemia.

Career Highlights

Shweta Urva is currently employed at Eli Lilly and Company, where she continues to innovate and develop new therapeutic methods. Her work is instrumental in advancing the understanding and treatment of metabolic disorders.

Collaborations

Some of her notable coworkers include Charles T Benson and Axel Haupt, who contribute to her research and development efforts.

Conclusion

Shweta Urva's contributions to the field of medical therapies are significant and impactful. Her innovative patents reflect her dedication to improving patient outcomes in glycemic control and weight management.